JP Morgan Private Wealth Advisors’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-19,500	Closed	-$90K	–	1295
2016 Q3	$90K	Hold	19,500	–	–	﹤0.01%	1189
2016 Q2	$113K	Sell	19,500 -735	-4%	-$4.68K	﹤0.01%	1203
2016 Q1	$123K	Buy	20,235 +2,235	+12%	+$13.4K	﹤0.01%	1127
2015 Q4	$164K	Hold	18,000	–	–	﹤0.01%	1044
2015 Q3	$102K	Hold	18,000	–	–	﹤0.01%	994
2015 Q2	$200K	Sell	18,000 -10,129	-36%	-$131K	﹤0.01%	979
2015 Q1	$441K	Buy	28,129 +10,129	+56%	+$157K	0.01%	758
2014 Q4	$274K	Sell	18,000 -10,297	-36%	-$125K	﹤0.01%	910
2014 Q3	$305K	Sell	28,297 -200	-0.7%	-$2.61K	﹤0.01%	844
2014 Q2	$435K	Buy	+28,497	New	+$410K	0.01%	608

Other funds holding SGMO

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FIC Capital New York $262M AUM 34.37% 1-Year Est. Return

JP Morgan Private Wealth Advisors's SGMO Position: Q4 2016 in Review

JP Morgan Private Wealth Advisors sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2016, closing a stake of 19,500 shares — an estimated $90K sold.

JP Morgan Private Wealth Advisors first reported a position in SGMO in Q2 2014 and held it in 10 quarters. The position peaked at $441K in Q1 2015. 126 funds tracked by Wall St. Rank hold SGMO as of Q4 2016.

JP Morgan Private Wealth Advisors reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2016 after selling out during the quarter.
JP Morgan Private Wealth Advisors sold 19,500 SANGAMO THERAPEUTICS INC shares in Q4 2016, an estimated $90K.
JP Morgan Private Wealth Advisors first reported a position in SANGAMO THERAPEUTICS INC in Q2 2014 and held it in 10 quarters.
JP Morgan Private Wealth Advisors's SANGAMO THERAPEUTICS INC position peaked at $441K in Q1 2015.
126 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2016.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.